Table of Contents
. Flowchart of the children included in the present study and in the regression models at each time point. Note: Cd, cadmium; GW, gestational week. Table S1 . Comparison of general characteristics in children with and without complete data at each exposure time point. Significant differences (p<0.05) are indicated by bold italic style. Table S2 . Results of the reference material included in the measurements of calcium concentrations in urine and cadmium concentrations in urine and blood (erythrocyte fraction). Figure S2 . Scatterplots of concurrent urinary cadmium concentrations with bone-related biomarkers at 9 years of age. Figure S3 . Scatterplots of urinary cadmium at 4.5 years of age with bone-related biomarkers at 9 years of age. Figure S4 . Scatterplots of urinary cadmium of the mothers at gestational week 8 and bone-related biomarkers at 9 years of age. Figure S5 . Scatterplots of concurrent erythrocyte cadmium with bone-related biomarkers at 9 years of age. Figure S6 . Scatterplots of erythrocyte cadmium at 4.5 years of age with bone-related biomarkers at 9 years of age. Figure S7 . Scatterplots of erythrocyte cadmium of the mothers at gestational week 14 with bonerelated biomarkers at 9 years of age. Table S3 . Spearman's rank correlation coefficients between biomarkers of exposure, covariates and bone-related markers at 9 years of age. n=504, except for TSH (n=299). Table S4 . Cadmium concentration in urine and erythrocytes and urinary arsenic (sum of metabolites) of the children at 9 and 4.5 years of age and in their mothers during pregnancy. Table S5 . Linear regression models of life-long cadmium exposure (erythrocyte concentrations at 9 and 4.5 years of age and of the mothers´ during pregnancy in the same model) with bone-related markers at 9 years of age. Figure S1 . Flowchart of the children included in the present study and in the regression models at each time point. Note: Cd, cadmium; GW, gestational week. Nov 2001 -Oct 2003 Live births (n=3625)
Pregnant women enrolled in MINIMat
Children followed up at 4.5 years (n=2735) 
.0 Note: UCd, urinary cadmium; Ery-Cd, erythrocyte cadmium, y, years; SES, socioeconomic status. U-Cd=Urinary cadmium, Ery-Cd=Erythrocyte cadmium, WAZ=Weight-for-age z-score, HAZ=Height-for-age z-score, SES=Socioeconomic status, M. edu.=Maternal education, Suppl.=Supplementation group during mother's pregnancy, U-As=Urinary arsenic (sum of metabolites), Hb=Hemoglobin, PTH=Parathyroid hormone, DPD=Deoxypyridinoline, U-Ca=Urinary calcium, IGF-1=Insulin-like growth factor 1, IGFBP3=Insulin-like growth factor-binding protein 3, TSH=Thyroid stimulating hormone. * means p-value<0.05
